We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
-18.78%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$33.5B
AUM Growth
-$7.23B
Cap. Flow
+$2.49B
Cap. Flow %
7.42%
Top 10 Hldgs %
22.78%
Holding
819
New
108
Increased
248
Reduced
319
Closed
97

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$349M
2
T icon
AT&T
T
+$127M
3
MMM icon
3M
MMM
+$118M
4
JCI icon
Johnson Controls International
JCI
+$117M
5
LHX icon
L3Harris
LHX
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 20.23%
2 Technology 19.12%
3 Financials 11.7%
4 Consumer Discretionary 10.23%
5 Industrials 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAG icon
376
Conagra Brands
CAG
$7.18B
$15.9M 0.05%
540,545
-12,400
-2% -$374K
VNTR
377
DELISTED
Venator Materials PLC
VNTR
$15.7M 0.05%
9,156,202
COHR icon
378
Coherent
COHR
$73.2B
$15.7M 0.05%
+550,000
New +$17.9M
GCP
379
DELISTED
GCP Applied Technologies Inc.
GCP
$15.4M 0.05%
867,459
-50,000
-5% -$1.06M
COO icon
380
Cooper Companies
COO
$14.5B
$15.4M 0.05%
223,532
-5,664
-2% -$461K
CDW icon
381
CDW
CDW
$17.1B
$15.3M 0.05%
164,000
-6,500
-4% -$796K
TFX icon
382
Teleflex
TFX
$5.98B
$15.3M 0.05%
52,121
-934
-2% -$326K
EQR icon
383
Equity Residential
EQR
$25.2B
$15.2M 0.05%
247,016
-48,779
-16% -$3.77M
TVTX icon
384
Travere Therapeutics
TVTX
$5.8B
$15.2M 0.05%
1,041,798
+966,798
+1,289% +$14.5M
COR icon
385
Cencora
COR
$61.5B
$15.1M 0.05%
170,800
-3,100
-2% -$273K
BCRX icon
386
BioCryst Pharmaceuticals
BCRX
$2.41B
$15M 0.04%
7,500,000
+3,500,000
+88% +$9.64M
STSA
387
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$14.9M 0.04%
693,625
AMCR icon
388
Amcor
AMCR
$22.1B
$14.9M 0.04%
366,738
-6,700
-2% -$321K
STML
389
DELISTED
Stemline Therapeutics, Inc.
STML
$14.9M 0.04%
3,068,829
-141,171
-4% -$915K
BBY icon
390
Best Buy
BBY
$17.2B
$14.8M 0.04%
259,700
-4,700
-2% -$373K
MKTX icon
391
MarketAxess Holdings
MKTX
$5.72B
$14.4M 0.04%
43,450
+14,200
+49% +$4.95M
HRL icon
392
Hormel Foods
HRL
$13.9B
$14.4M 0.04%
308,946
-15,200
-5% -$691K
AMAL icon
393
Amalgamated Financial
AMAL
$1.49B
$14.3M 0.04%
1,324,875
+566,870
+75% +$9.08M
GLW icon
394
Corning
GLW
$143B
$14.3M 0.04%
696,321
-98,400
-12% -$2.57M
CBRE icon
395
CBRE Group
CBRE
$43.4B
$14.3M 0.04%
378,200
-6,900
-2% -$381K
IP icon
396
International Paper
IP
$22.1B
$14.2M 0.04%
481,316
-8,554
-2% -$317K
SJM icon
397
J.M. Smucker
SJM
$12.9B
$14.1M 0.04%
126,927
-2,400
-2% -$257K
CCXI
398
DELISTED
ChemoCentryx, Inc.
CCXI
$14.1M 0.04%
350,000
+50,000
+17% +$2.12M
PNR icon
399
Pentair
PNR
$11.2B
$14M 0.04%
470,937
+363,985
+340% +$14.6M
EXR icon
400
Extra Space Storage
EXR
$31.6B
$14M 0.04%
146,300
-2,700
-2% -$281K

Similar funds

Adage Capital Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Adage Capital Partners held 819 positions worth $33.5B, down 18% from $40.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Adage Capital Partners deployed $2.49B of net new capital in Q1 2020, opening 108 new positions and adding to 248 existing holdings. Its largest new stake was Raytheon Company: 818,400 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was RTX Corp, an estimated $349M trimmed.

  • Adage Capital Partners's largest Q1 2020 buy was Raytheon Company: 818,400 shares worth $107M.
  • Adage Capital Partners added most to Allergan plc in Q1 2020, an estimated $526M increase.
  • Adage Capital Partners's biggest Q1 2020 reduction was RTX Corp, cutting an estimated $349M.
  • Adage Capital Partners fully exited 3M in Q1 2020, selling an estimated $118M.
  • Adage Capital Partners's ten largest holdings make up 23% of its $33.5B portfolio in Q1 2020.
  • Adage Capital Partners opened 108 new positions and closed 97 in Q1 2020.
  • Adage Capital Partners's portfolio value fell 18% quarter-over-quarter to $33.5B.

Based on Adage Capital Partners's 13F filing for Q1 2020, filed 15 May 2020.